BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 30684445)

  • 1. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries.
    Kayssi A; Al-Jundi W; Papia G; Kucey DS; Forbes T; Rajan DK; Neville R; Dueck AD
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012510. PubMed ID: 30684445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs.
    Kayssi A; Al-Atassi T; Oreopoulos G; Roche-Nagle G; Tan KT; Rajan DK
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011319. PubMed ID: 27490003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravascular brachytherapy for peripheral vascular disease.
    Andras A; Hansrani M; Stewart M; Stansby G
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003504. PubMed ID: 24399686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-eluting stents for revascularization of infrapopliteal arteries: updated meta-analysis of randomized trials.
    Fusaro M; Cassese S; Ndrepepa G; Tepe G; King L; Ott I; Nerad M; Schunkert H; Kastrati A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1284-93. PubMed ID: 24355118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia.
    Hsu CC; Kwan GN; Singh D; Rophael JA; Anthony C; van Driel ML
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009195. PubMed ID: 30536919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
    Caradu C; Lakhlifi E; Colacchio EC; Midy D; Bérard X; Poirier M; Ducasse E
    J Vasc Surg; 2019 Sep; 70(3):981-995.e10. PubMed ID: 31126769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of femoropopliteal artery drug-eluting balloons and drug-eluting stents (FOREST trial): Study protocol for a randomized controlled trial.
    Jongsma H; van Mierlo-van den Broek P; Imani F; van den Heuvel D; de Vries JPM; Fioole B
    J Vasc Surg; 2017 Oct; 66(4):1293-1298. PubMed ID: 28826727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty in patients with femoropopliteal arterial occlusive disease.
    Jongsma H; Bekken JA; de Vries JP; Verhagen HJ; Fioole B
    J Vasc Surg; 2016 Nov; 64(5):1503-1514. PubMed ID: 27478005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
    Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherectomy for peripheral arterial disease.
    Wardle BG; Ambler GK; Radwan RW; Hinchliffe RJ; Twine CP
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD006680. PubMed ID: 32990327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery).
    Liistro F; Grotti S; Porto I; Angioli P; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1295-302. PubMed ID: 24239203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial.
    Teichgräber U; Aschenbach R; Scheinert D; Zeller T; Brechtel K; Thieme M; Blessing E; Treitl M; Lichtenberg M; von Flotow P; Vogel B; Werk M; Riambau V; Wienke A; Lehmann T; Sixt S
    Trials; 2016 Oct; 17(1):528. PubMed ID: 27793175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial.
    Fanelli F; Cannavale A; Boatta E; Corona M; Lucatelli P; Wlderk A; Cirelli C; Salvatori FM
    J Endovasc Ther; 2012 Oct; 19(5):571-80. PubMed ID: 23046320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel-coated versus uncoated balloon angioplasty for femoropopliteal artery in-stent restenosis.
    Wu R; Li Z; Wang M; Chang G; Yao C; Wang S
    Int J Surg; 2017 Jun; 42():72-82. PubMed ID: 28461145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of Legflow(®) paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): study protocol for a randomized controlled trial.
    Karimi A; de Boer SW; van den Heuvel DA; Fioole B; Vroegindeweij D; Heyligers JM; Lohle PN; Elgersma O; Nolthenius RP; Vos JA; de Vries JP
    Trials; 2013 Mar; 14():87. PubMed ID: 23537403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
    Grotti S; Liistro F; Angioli P; Ducci K; Falsini G; Porto I; Ricci L; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    J Endovasc Ther; 2016 Feb; 23(1):52-7. PubMed ID: 26511896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Randomized Freeway Stent Study: Drug-Eluting Balloons Outperform Standard Balloon Angioplasty for Postdilatation of Nitinol Stents in the SFA and PI Segment.
    Tacke J; Müller-Hülsbeck S; Schröder H; Lammer J; Schürmann K; Gross-Fengels W; Fischbach R; Textor J; Boguth L; Loewe C; Häuser H; Gschwendtner M; Tepe G; von Strandmann RP; Stahnke S; Dambach J; Hausegger K
    Cardiovasc Intervent Radiol; 2019 Nov; 42(11):1513-1521. PubMed ID: 31432220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angioplasty versus stenting for iliac artery lesions.
    Jongsma H; Bekken J; Ayez N; Hoogewerf CJ; Van Weel V; Fioole B
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD007561. PubMed ID: 33258499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.